Alternatives to oxybutynin
FDA shortage status is active for oxybutynin; 1 same-class SPL records are listed below for registry comparison only.
Brand: Ditropan
oxybutynin class peers while FDA lists an active shortage
oxybutynin (Ditropan) is on an FDA shortage listing while 1 other Anticholinergic / Antispasmodic SPL records remain in this registry peer set (class inventory 2). Labeled indication field for oxybutynin: This medicine treats overactive bladder.
Top FAERS reaction fields for oxybutynin total 11,432 reports across 10 reactions, set beside dicyclomine. Counts are exposure-weighted submissions, not per-patient risk.
About oxybutynin
Oxybutynin extended-release tablets help control an overactive bladder. It reduces the feeling of needing to go to the bathroom often.
Used for: This medicine treats overactive bladder. It helps with symptoms like needing to urinate frequently, feeling a sudden urge to urinate, and leaking urine. It can also treat overactive bladder in children 6 years and older caused by nerve problems.
1 Anticholinergic / Antispasmodic peers (wide set)
oxybutynin vs dicyclomine · FAERS reaction fields
FAERS top-reaction field "Fall" shows the widest count spread between oxybutynin and dicyclomine in this extract (914-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.
| Side Effect | oxybutynin | dicyclomine |
|---|---|---|
| Fatigue | 1,539 | 1,119 |
| Fall | 1,467 | 553 |
| Nausea | 1,211 | 1,251 |
| Dizziness | 1,144 | 688 |
| Diarrhoea | 1,079 | 1,193 |
| Pain | 1,077 | 1,003 |
| Urinary Tract Infection | 1,043 | - |
| Headache | 991 | 861 |
"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.
oxybutynin shortage vs Anticholinergic / Antispasmodic peer index
Shortage status
FDA shortage listing is active for oxybutynin (status: To Be Discontinued). Peer rows remain a registry index, not a switch guide.
Frequently Asked Questions
Does FDA list a shortage for oxybutynin while peers remain indexed? ▼
Registry note: Shortage listings and peer indexes are for registry orientation only. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.
Field note for oxybutynin: see also the generic vs brand label guide when reading Ditropan SPL strings.
Read our methodology - how this data is sourced, computed, and verified.